October 30, 2014

The affiliated companies of Community Care of North Carolina, along with GlaxoSmithKline and the UNC Eshelman School of Pharmacy, on Thursday announced their intent to develop, implement and test new approaches to care delivery. 

October 30, 2014

AstraZeneca on Thursday announced that the Food and Drug Administration approved Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily drug for the treatment of adults with Type 2 diabetes. 

October 30, 2014

Sandoz, through its branded dermatology business PharmaDerm, and Medigene AG on Thursday announced a promotion agreement with Women's Choice Pharmaceuticals for Veregen (sinecatechins) ointment, 15% strength. 

October 28, 2014

Novartis announced that it has entered into a definitive agreement to divest its influenza vaccines business to CSL for an agreed price of $275 million.

 

October 27, 2014

Rx Response moved to alert status in response to the concern about Ebola in the United States.

October 24, 2014

Pfizer on Thursday announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules.

October 23, 2014

Actavis on Thursday confirmed that the United States Court of Appeals for the Federal Circuit has upheld a lower court ruling that found United States Patent No. 7,704,984 (the '984 Patent) to be valid.

October 23, 2014

GlaxoSmithKline expects to have its Ebola vaccine available by year's end.

October 23, 2014

The U.S. healthcare system must address the problem of patients not picking up newly-prescribed medicines, according to a NEHI white paper.

October 23, 2014

The Pharmaceutical Research and Manufacturers of America earlier this week announced that Christina Stow will join the organization as VP communications, effective Oct. 27. 

October 22, 2014

Pfizer last week announced that the Food and Drug Administration approved a revised label for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release capsules, for oral use, CII, to include abuse-deterrence studies. 

 

October 22, 2014

The pharmaceutical industry has committed considerable resources to developing both vaccines and treatments to address the current Ebola crisis.

 

October 22, 2014

Adult millennials ages 18 years to 32 years worry about their health and access to health care as much as their baby boomer elders.

October 21, 2014

Boehringer Ingelheim Pharmaceuticals on Monday announced that Ofev (nintedanib) capsules are now available in the United States. Ofev was approved by the Food and Drug Administration on Oct. 15 to treat idiopathic pulmonary fibrosis.

October 21, 2014

H.D. Smith on Monday appointed Rob Meriweather as VP sales.

 

October 21, 2014

McKesson and Health Mart on Monday featured solutions designed to help community pharmacies deliver better patient care and sustain growth.

 

October 21, 2014

A team of scientists, led by researchers at the Wistar Institute, has identified a possible explanation for why middle-aged adults were hit especially hard by the H1N1 influenza virus during the 2013-14 influenza season.

 

October 20, 2014

Cardinal Health on Monday announced that independent pharmacies can now take advantage of opportunities to co-brand with the Medicine Shoppe and Medicap Pharmacy franchising systems.

October 17, 2014

Healthentic, an analytics company that identifies health savings for employers, found the overall vaccination rate of employees was only 10%.

October 17, 2014

Purdue Pharma has launched an awareness campaign to address specific knowledge gaps among pharmacists related to its Schedule III extended-release transdermal opioid, Butrans.

October 16, 2014

The Food and Drug Administration has granted approval to Esbriet (pirfenidone), as well as Ofev (nintedanib), to treat idiopathic pulmonary fibrosis — a condition in which the lungs scar over time.

October 16, 2014

 Big Belli on Thursday announced the December 2014 premiere of a documentary called “40 Weeks.” 

October 15, 2014

 H. D. Smith was recently announced as a finalist of the 2014 Illinois Family Business of the Year Awards in the Large Family Business of the Year and the Community Service categories.

October 15, 2014

Mission Pharmacal Co. on Tuesday announced that the U.S. District Court for the Western District of Texas has issued a consent judgment confirming the validity of its dual-iron patent.